Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
Aakash Desai, Sonia Sandhu, Jinping Lai, et al.
World Journal of Hepatology (2019) Vol. 11, Iss. 1, pp. 1-18
Open Access | Times Cited: 279

Showing 1-25 of 279 citing articles:

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang, Hashem B. El–Serag, Rohit Loomba
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 4, pp. 223-238
Open Access | Times Cited: 1358
Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management
Thomas Marjot, Ahmad Moolla, Jeremy Cobbold, et al.
Endocrine Reviews (2019) Vol. 41, Iss. 1, pp. 66-117
Open Access | Times Cited: 194
Fontan-Associated Liver Disease
Juliet Emamaullee, Ali N. Zaidi, Thomas D. Schiano, et al.
Circulation (2020) Vol. 142, Iss. 6, pp. 591-604
Open Access | Times Cited: 175
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
Do Young Kim
Journal of Liver Cancer (2024) Vol. 24, Iss. 1, pp. 622-70
Open Access | Times Cited: 51
The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
Joscha Vonderlin, Triantafyllos Chavakis, Michael H. Sieweke, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 6, pp. 1311-1324
Open Access | Times Cited: 50
New potent HBV replication inhibitors for the management of chronic hepatitis B are needed
Timothy M. Block, Ju‐Tao Guo, Fabien Zoulim, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 2
Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease
Diwakar Suresh, Akshatha N. Srinivas, Divya P. Kumar
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 134
Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
Moris Sangineto, Rosanna Villani, Francesco Cavallone, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1419-1419
Open Access | Times Cited: 130
RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer
Yueyue Yang, Jiafei Lin, Susu Guo, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 130
<p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>
Srikanta Dash, Yücel Aydın, Kyle E Widmer, et al.
Journal of Hepatocellular Carcinoma (2020) Vol. Volume 7, pp. 45-76
Open Access | Times Cited: 93
The Role of the Gut Microbiome in Liver Cirrhosis Treatment
Na Young Lee, Ki Tae Suk
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 199-199
Open Access | Times Cited: 87
Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances
Khaled Y. Mahmoud, Shady A. Swidan, Mohamed A. El-Nabarawi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 66
Viral hepatitis: Past, present, and future
Matthew A. Odenwald, Sonali Paul
World Journal of Gastroenterology (2022) Vol. 28, Iss. 14, pp. 1405-1429
Open Access | Times Cited: 66
Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
Lampros Chrysavgis, Ilias Giannakodimos, Panagiota Diamantopoulou, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 3, pp. 310-331
Open Access | Times Cited: 57
Therapeutic Effects of Crocin Alone or in Combination with Sorafenib against Hepatocellular Carcinoma: In Vivo & In Vitro Insights
Suzan Abdu, Nouf Juaid, Amr Amin, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1645-1645
Open Access | Times Cited: 49
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions
Jack Leslie, Daniel Geh, Ahmed M. Elsharkawy, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 1, pp. 219-236
Open Access | Times Cited: 39
Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B
Manfred Schmidt, Graham R. Foster, Michiel Coppens, et al.
Blood Advances (2023) Vol. 7, Iss. 17, pp. 4966-4969
Open Access | Times Cited: 35
Fe-MnO2 nanosheets loading dihydroartemisinin for ferroptosis and immunotherapy
Dandan Huang, Dafen Xu, Wenxin Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114431-114431
Open Access | Times Cited: 28
Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review
Gianvito Candita, Sara Rossi, Karolina Cwiklinska, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 625-625
Open Access | Times Cited: 25
DNA methylation markers in the detection of hepatocellular carcinoma
Siyu Fu, José D. Debes, André Boonstra
European Journal of Cancer (2023) Vol. 191, pp. 112960-112960
Open Access | Times Cited: 25
Alcohol-associated liver cancer
Yaojie Fu, Luca Maccioni, Xin Wei Wang, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1462-1479
Closed Access | Times Cited: 11
Metabolic Cause of Cirrhosis Is the Emerging Etiology for Primary Liver Cancer in the Asia‐Oceania Region: Analysis of Global Burden of Disease (GBD) Study 2021
Suprabhat Giri, Sushrut Ingawale, Gaurav Khatana, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access | Times Cited: 1
Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study
Magdalena Stępień, Pekka Keski‐Rahkonen, Agnèta Kiss, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 3, pp. 609-625
Open Access | Times Cited: 62
The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma
Yi‐Te Lee, Benjamin V. Tran, Jasmine J. Wang, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 3076-3076
Open Access | Times Cited: 49
Hepcidin in hepatocellular carcinoma
Jonathan H. Joachim, Kosha J. Mehta
British Journal of Cancer (2022) Vol. 127, Iss. 2, pp. 185-192
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top